From the Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology; and Hubei Key Laboratory of Molecular Imaging, Wuhan, China.
Received for publication March 20, 2021; revision accepted September 13, 2021.
X.Z. and W.S. contributed equally to this work.
Conflicts of interest and sources of funding: This work was supported by the National Natural Science Foundation of China (no. 82030052 and 81901783). The authors declare no conflicts of interest.
Clinical Trial Registration: NCT04605939 and NCT04554719.
Ethical approval: All procedures involving human participants were carried out in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Authors' contributions: X. L. conceived and designed the study devised, and supervised the project. X. Z. and W. S. wrote the manuscript. X. L., C. Q., and F. L. analyzed the image data. Y. S. and F. H. contributed to the follow-up of the patients.
Correspondence to: Xiaoli Lan, MD, PhD, Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Jiefang Ave, Wuhan, Hubei Province 430022, China. E-mail: [email protected], [email protected].
